Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-08-01

Clinical Trial Update: Evaluation of Hypoallergenicity of a New Extensively Hydrolyzed Formula [NA]

View source ↗

Summary

Completed clinical trial evaluating whether a new extensively hydrolyzed formula is hypoallergenic for individuals with cow's milk allergy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Extensively Hydrolyzed Formula for Cow's Milk Allergy (Extensively hydrolyzed formula)

Snippet

Sponsor: Société des Produits Nestlé (SPN) | Conditions: Cow's Milk Allergy | NA | Status: COMPLETED